• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Pharma & Human Health

Finance

Axial Biotherapeutics Raises $25 Million in Series B Financing

February 28, 2019 Microbiome Times

Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative and neuropsychiatric diseases, today announced the completion of a $25 million series B equity financing. New investor Seventure Partners, […]

Pharma & Human Health

Acurx Announces First-In-Man Clinical Trial Data of ACX-362E for CDI

February 28, 2019 Microbiome Times

Acurx Pharmaceuticals, LLC (“Acurx” or the “Company”), a privately-held, clinical stage, biopharmaceutical company developing new antibiotics for difficult-to-treat bacterial infections, announced today that its lead product candidate, ACX-362E, has successfully completed the 32-subject, double-blinded, placebo-controlled, […]

Finance

KNOW Bio Announces Creation of Digestive Health Therapeutics, Inc.

February 28, 2019 Microbiome Times

KNOW Bio, LLC., (the Company), a North Carolina developer of nitric oxide-based medical technology and related biotechnology companies, announced that the Company has formed a new wholly-owned operating subsidiary, Digestive Health Therapeutics, Inc, to develop […]

Finance

DuPont Nutrition & Health and Lonza Specialty Ingredients Announce Joint Agreement in Human Milk Oligosaccharides

February 28, 2019 Microbiome Times

DuPont Nutrition & Health and Lonza Specialty Ingredients announce an agreement under which the leading biotechnology and specialty ingredient company Lonza will manufacture and supply CARE4U™ 2’-FL – a human milk oligosaccharide (HMOs). This strategic […]

Animal Health

New ‘interspecies communication’ strategy between gut bacteria and mammalian hosts uncovered

February 22, 2019 Microbiome Times

Bacteria in the gut do far more than help digest food in the stomachs of their hosts, they can also tell the genes in their mammalian hosts what to do. A study published today in […]

Finance

BiomX Raises $32 Million in Series B Financing

February 20, 2019 Microbiome Times

BiomX Ltd., a microbiome company developing customized phage therapies, announced the closing of a $32 million series B equity financing. The financing was led by existing investors OrbiMed, Johnson & Johnson Innovation – JJDC, Inc., […]

Finance

S-Biomedic Completes Series A Round With DSM Venturing

February 18, 2019 Microbiome Times

S-Biomedic, a pioneer in patented human microbiome skin applications, announces the successful completion of their second Series A financing round. The second closing welcomed a new investor, DSM Venturing and was also supported by existing […]

Pharma & Human Health

Newly isolated human gut bacterium reveals possible connection to depression

February 15, 2019 Microbiome Times

“The association of microbial GABA metabolism [the brain protein gamma-aminobutyric acid (GABA)] with mental health is highly compelling.” Jack Gilbert, Argonne microbial ecologist Researchers have established a correlation between depression and a group of neurotransmitter-producing […]

Editor's Choice

Jeffrey Gordon wins the Frontiers of Knowledge Award for pioneering microbiome research

February 14, 2019 Microbiome Times

The BBVA Foundation Frontiers of Knowledge Award in the Biology and Biomedicine category has gone in this eleventh edition to American researcher Jeffrey Gordon, for his fundamental discovery of the importance of the gut microbial […]

Editor's Choice

More than 100 new gut bacteria discovered in human microbiome

February 8, 2019 Microbiome Times

Scientists working on the gut microbiome* have discovered and isolated more than 100 completely new species of bacteria from healthy people’s intestines. The study from the Wellcome Sanger Institute, Hudson Institute of Medical Research, Australia, […]

Finance

Viome acquires Habit from Campbell Soup Company

February 7, 2019 Microbiome Times

Viome announces it has entered into an agreement with Campbell Soup Company (NYSE:CPB) to acquire Habit, a leading personalized nutrition company that takes the guesswork out of eating right. Now operating as one, the two […]

Posts navigation

« 1 … 65 66 67 … 85 »

Sign Up to Free Newsletter

Editor’s Choice

  • Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study
    November 17, 2025
  • The OMNIgene™•VAGINAL device – Optimized solutions for vaginal microbiome studies
    November 12, 2025
  • MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline
    September 4, 2025
  • Targeting the ileo-colonic region: Innovative solutions for sensitive APIs
    August 21, 2025
  • EXPERT’Biome CDMO by Lallemand at Microbiome Times Forum
    June 23, 2025
sign up

Sign up to the Microbiome Times newsletter